Schedule Companion Medical’s Clinical Expert for your next Grand Rounds about smart insulin pens and data-driven care for MDI therapy.
LEARN MORE >>

Demystify your patients' MDI therapy

InPen empowers you with actionable data you've never had from your MDI patients, until now.

InPen helps solve common MDI challenges​

InPen now offers tracking and decision support for MDI patients ages 7 and up. (Under age 7 adult supervision only.)

drop icon

Missing 2 doses
per week can lead
to an increase in
A1c of up to 0.4%1

plus icon

2/3 of people need
help calculating
their doses and 60%
of doses are stacked2-4

arrow icon

Lack of accurate
dosing data is a
barrier to optimizing
glycemic control5

person icon

The use of a bolus
calculator is associated
with a 0.7-1.0%
reduction in A1c6-8

No conference? No problem!

Visit InPen's virtual conference booth to learn about the latest InPen features.

Finally, a system that makes life easier for you and your patients

Advanced tracking and algorithms, along with intuitive reports, tell you and your patients more about their MDI therapy than ever before.

Full visibility of patient data

Patients can share their InPen data with you at any time. See when and how much your patients are dosing, and get full visibility into their blood glucose and carb intake. At their next appointment, you can collaborate and identify new ways to achieve their goals.

insights report tablet
doctor with pediatric patient

Clear data, better patient outcomes

Data can make treatment more time-intensive, but InPen reports do the interpretation for you. They're easy to read and reveal all the information you need to make decisions.

Intuitive, affordable decision support

InPen helps MDI users take the right amount of insulin at the right time, thanks to real-time tracking and decision support.

  • Tracks active insulin
  • Reminds user to dose
  • Calculates personalized doses
  • Automatically logs doses
  • Syncs with CGMs and glucose meters
inpen pricing
Eligibility Requirements for InPen™ Patient Access Program: Open to uninsured patients and patients with commercial prescription insurance and who are not enrolled in any government-funded program that pays for prescription devices or treatments. Excluded participants include patients enrolled in any federal, state, or government-funded healthcare program such as Medicare, Medicare Advantage, Medicare Part D, Medicaid, Medigap, Veterans Affairs (VA), the Department of Defense (DoD) or TRICARE® that provides coverage for InPen, or where prohibited by law. Cash Discount Cards and other non-insurance plans are not valid as primary under this offer. If at any time a patient becomes enrolled under any such federal, state, or government-funded healthcare program, he/she will no longer be able to use this program and must call [insert number] to stop participation. Restrictions may apply. Offer subject to change or discontinuation without notice. This is not health insurance. Offer applies to a maximum of 2 prescribed InPens per Patient per benefit year. Offer good only in the USA at participating pharmacies and cannot be redeemed at government-subsidized clinics.

Patients with diabetes are looking for easy ways to track their data as today’s world embraces technology. Providers are looking for more data to help manage diabetes. The InPen has the ability to do both by giving the patient a calculator to help with dosing, reminders to dose, and recommendations — while giving the providers useful downloaded information in the office and remotely as well.”

- Heather Rush, MSN APRN CPNP CDE MLDE

A solution for all diabetes patients

InPen offers easy, affordable decision support for Type 1 and Type 2 patients ages 7 and up*.

fixed-dose-patient

Sharon

Type 2, fixed dose

“I take a set amount of insulin with each meal.”​

Sharon will receive InPen dose recommendations based on a fixed amount for each meal. When a current blood glucose is provided, the dose calculator may add insulin to the fixed meal dose recommendation to correct for glucose values above target. She can safely correct high glucose between meals because InPen will recommend correction doses based on her active insulin.

Katie

Type 2, meal estimation

“I estimate the size of my meals.”

Katie's dose recommendations in the InPen app are based on an estimate of the number of carbohydrates in each meal (i.e., low, medium, high carb meals). When a current blood glucose is provided, the dose calculator may add insulin to the meal estimation dose recommendation to correct for glucose values above target. She can safely correct high glucose between meals because InPen will recommend correction doses based on her active insulin.

meal-estimation-patient
meal-estimation-patient

Katie

Type 2, meal estimation

“I estimate the size of my meals.”

Katie's dose recommendations in the InPen app are based on an estimate of the number of carbohydrates in each meal (i.e., low, medium, high carb meals). When a current blood glucose is provided, the dose calculator may add insulin to the meal estimation dose recommendation to correct for glucose values above target. She can safely correct high glucose between meals because InPen will recommend correction doses based on her active insulin.

carb counter showcase

Jack

Type 1, carb counting

“I count the number of carbs in each meal.”

Jack's dose recommendations are based on the exact amount of carbohydrates he eats. The app calculates his doses using an insulin-to-carb ratio. When a current blood glucose is provided, the dose calculator may adjust insulin recommendations to correct for glucose values outside of target. He can safely correct high glucose between meals because InPen will recommend correction doses based on his active insulin.

Prescription information

Frequently asked questions

InPen is a prescription-only device. Eligible patients with commercial insurance may pay as little as $35 per prescribed InPen. Each InPen is reusable for one year. Terms and conditions apply – learn more.  Complete this form for a free, no-obligation verification of your insurance benefits.

You can prescribe InPen through EMR or our start order form. Learn more about how to prescribe InPen here.

If you need to adjust your patient’s therapy mode (dose calculator) in the InPen app, please contact our technical support team at 844-843-7903, option 1.

Your patient can send their Insights Report to you directly from their InPen app. Learn more here.

Our trained InPen Specialists are available for virtual 1-on-1 training sessions Monday through Friday from 6am – 6pm PT. We ask that patients contact their doctor with questions about their therapy settings,
insulin regimen, or blood glucose concerns.

More questions? Visit our FAQ Page

Give your patients a smarter diabetes management tool.

*Ages 7 and older, or under the supervision of an adult caregiver.

1.  Randlov, J., Poulsen, J.U. J Diabetes Sci Technol. 2008 Mar; 2(2): 229-235. Published online 2008 Mar. doi: [10.1177/1932296 80800200209]

2.  Garg SK, Bookout TR, McFann KK, et al. Improved glycemic control in intensively treated adult subjects with type 1 diabetes using insulin guidance software. Diabetes Technology and Therapeutics. 2008; 10(5):369-375.

3.  Zaugg, Stephanie D., et al. “Diabetes numeracy and blood glucose control: association with type of diabetes and source of care.” Clinical diabetes: a publication of the American Diabetes Association 32.4 (2014): 152-157.

4.  Cavanaugh, Kerri, et al. “Association of numeracy and diabetes control.” Annals of Internal Medicine 148.10 (2008): 737-746.

5.  Klonoff DC, Kerr D. Smart Pens Will Improve Insulin Therapy. J Dia Sci & Tech, 2018;12(3):551-553.

6.  Ziegler R, Cavan DA, Cranston I, et al. Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy patients with suboptimal glycemic control: first results from the ABACUS trial. Diabetes Care. 2013; 36(11):3613-3619.

7.  Kaufman FR, Halvorson M, Carpenter S. Use of a plastic insulin dosage guide to correct blood glucose levels out of the target range and for carbohydrate counting in subjects with type 1 diabetes. Diabetes Care. 1999; 22(8):1252-1257.

8.  Anderson DG. Multiple daily injections in young patients using the ezy-BICC bolus insulin calculation card, compared to mixed insulin and CSII. Pediatric Diabetes. 2009; 10(5):304-309